Biosidus Overview
- Year Founded
-
1983

- Status
-
Private
- Employees
-
363

- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
2
Biosidus General Information
Description
Manufacturer of biosimilar pharmaceuticals based in Buenos Aires, Argentina. The company specializes in pharmaceutical ingredients along with therapeutic proteins that focus on the treatment of chronic renal failure, cancer, multiple sclerosis, growth hormone deficiency and osteoporosis as well as develops technological platforms in transgenic animals, gene therapy and biodiversity and undertakes the operations of aseptic filling, lyophilization and tablet packing through extensive research and development, bacterial fermentation and massive cell culture, enabling a greater number of patients to have access to biological treatments.
Contact Information
Website
www.biosidus.com.arCorporate Office
- Constitucion 4234
- Buenos Aires, C1254ABX
- Argentina
Corporate Office
- Constitucion 4234
- Buenos Aires, C1254ABX
- Argentina
Biosidus Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Biosidus Comparisons
Industry
Financing
Details
Biosidus Competitors (85)
One of Biosidus’s 85 competitors is IVERIC bio, a Formerly VC-backed company based in Parsippany, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
IVERIC bio | Formerly VC-backed | Parsippany, NJ | ||||
Xenetic Bioscience | Corporation | Framingham, MA | ||||
GlobeImmune | Formerly VC-backed | Louisville, CO | ||||
Dermavant Sciences | Formerly PE-Backed | Long Beach, CA | ||||
TheraSource | Corporation | Manhasset, NY |
Biosidus Patents
Biosidus Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-7022326-B1 | Derived from the tat protein of hiv-1; biological inactive but preserve their immunogenicity; a fusion protein comprising a retroviral regulatory protein fused to a heterologous polypeptide; biodrugs or vaccines for preventing retroviral infections | Inactive | 26-Dec-1997 |
Biosidus Signals
Biosidus Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Biosidus FAQs
-
When was Biosidus founded?
Biosidus was founded in 1983.
-
Where is Biosidus headquartered?
Biosidus is headquartered in Buenos Aires, Argentina.
-
What is the size of Biosidus?
Biosidus has 363 total employees.
-
What industry is Biosidus in?
Biosidus’s primary industry is Pharmaceuticals.
-
Is Biosidus a private or public company?
Biosidus is a Private company.
-
What is Biosidus’s current revenue?
The current revenue for Biosidus is
. -
Who are Biosidus’s investors?
ACON Investments has invested in Biosidus.
-
Who are Biosidus’s competitors?
IVERIC bio, Xenetic Bioscience, GlobeImmune, Dermavant Sciences, and TheraSource are some of the 85 competitors of Biosidus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »